Who
Alan H. Auerbach
President and CEO
Company insider
Files Form 4 as: President and CEO, Puma Biotechnology; Director, Radius Health; President and CEO, Cougar Biotechnology.
In numbers
- Trades disclosed
- 123
- Buys
- 0
- Sells
- 65
- Bought
- $0
- Sold
- $6.5M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 28 Sep 2006
- Last trade
- 6 Jul 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 8 Jul 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $364K44,058 at $8.26 | filing |
| 6 Jul 2026filed 8 Jul 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $364K44,058 at $8.26 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —159,778 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —227,474 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —227,474 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —159,778 at $0.00 | filing |
| 7 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $106K18,012 at $5.88 | filing |
| 7 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $106K18,012 at $5.88 | filing |
| 6 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $99K16,938 at $5.84 | filing |
| 6 Jan 2026filed 8 Jan 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $99K16,938 at $5.84 | filing |
| 9 Jul 2025filed 10 Jul 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $76K21,580 at $3.54 | filing |
| 8 Jul 2025filed 10 Jul 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $90K25,592 at $3.53 | filing |
| 7 Feb 2025filed 11 Feb 2025 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —274,622 at $0.00 | filing |
| 7 Feb 2025filed 11 Feb 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —198,399 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $107K33,841 at $3.15 | filing |
| 17 Jul 2024filed 18 Jul 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $81K21,920 at $3.70 | filing |
| 2 Jul 2024filed 2 Jul 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $62K18,885 at $3.27 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,047 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —6,577 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | PBYI Puma Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —222,573 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.